J Pediatr Infect Dis 2019; 14(04): 155-160
DOI: 10.1055/s-0039-1683388
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Community-Acquired Pneumonia Due to Virus and Mycoplasma pneumoniae Infection in Children Younger than 5 Years

Huiming Sun*
1   Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China
,
Wenqing Zhu*
2   Department of Pharmacy, Children's Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China
,
Zhengrong Chen
1   Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China
,
Wei Ji
1   Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China
,
Chuangli Hao
1   Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China
,
Zhang Xinxing
1   Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China
,
Gu Wenjing
1   Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China
,
Yuqing Wang
1   Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China
› Author Affiliations
Further Information

Publication History

26 July 2018

01 February 2019

Publication Date:
07 March 2019 (online)

Abstract

The purpose of this study was to determine the clinical features of viral pathogens and Mycoplasma pneumoniae in children hospitalized with community-acquired pneumonia (CAP). M. pneumoniae infection was diagnosed by both serology and polymerase chain reaction (PCR). Respiratory viruses were detected by direct immunofluorescence or PCR. Medical records of children younger than 5 years diagnosed with 5-day-old CAP were reviewed. Viral pathogens and/or M. pneumoniae were detected in 388 (15.59%) children in the following three groups: viral monoinfection (n = 321), M. pneumoniae with viral coinfection (n = 17), and M. pneumoniae monoinfection (n = 50). M. pneumoniae monoinfection was characterized by older age, fever, higher neutrophil count, and chest X-ray showing lobar consolidation. Wheezing was more common in children with viral infections. Elevated alanine aminotransferase and aspartate aminotransferase were commonly seen in children with Mycoplasma infections. The median symptom duration in children with viral coinfection was shorter than in the other two groups (both p < 0.05). M. pneumoniae and respiratory viruses are important etiologic agents for CAP in children younger than 5 years, with characteristic clinical features. M. pneumoniae and viral coinfection are associated with shorter duration of symptoms before admission.

Ethical Approval

All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendment or comparable ethical standards.


Informed Consent

Informed consent was obtained from all individual participants included in the study.


* Huiming Sun and Wenqing Zhu contributed equally to this study.


 
  • References

  • 1 Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet 2011; 377 (9773): 1264-1275
  • 2 Esposito S, Principi N. Emerging resistance to antibiotics against respiratory bacteria: impact on therapy of community-acquired pneumonia in children. Drug Resist Updat 2002; 5 (02) 73-87
  • 3 Hammerschlag MR. Mycoplasma pneumoniae infections. Curr Opin Infect Dis 2001; 14 (02) 181-186
  • 4 Principi N, Esposito S, Blasi F, Allegra L. ; Mowgli study group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001; 32 (09) 1281-1289
  • 5 Defilippi A, Silvestri M, Tacchella A. , et al. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med 2008; 102 (12) 1762-1768
  • 6 Morozumi M, Hasegawa K, Chiba N. , et al. Application of PCR for Mycoplasma pneumoniae detection in children with community-acquired pneumonia. J Infect Chemother 2004; 10 (05) 274-279
  • 7 Othman N, Isaacs D, Kesson A. Mycoplasma pneumoniae infections in Australian children. J Paediatr Child Health 2005; 41 (12) 671-676
  • 8 Juvén T, Mertsola J, Waris M. , et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000; 19 (04) 293-298
  • 9 Cevey-Macherel M, Galetto-Lacour A, Gervaix A. , et al. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr 2009; 168 (12) 1429-1436
  • 10 Bezerra PG, Britto MC, Correia JB. , et al. Viral and atypical bacterial detection in acute respiratory infection in children under five years. PLoS One 2011; 6 (04) e18928
  • 11 Chiu CY, Chen CJ, Wong KS, Tsai MH, Chiu CH, Huang YC. Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia. J Microbiol Immunol Infect 2015; 48 (01) 51-56
  • 12 Xu D, Li S, Chen Z, Du L. Detection of Mycoplasma pneumoniae in different respiratory specimens. Eur J Pediatr 2011; 170 (07) 851-858
  • 13 Bradley JS, Byington CL, Shah SS. , et al; Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53 (07) e25-e76
  • 14 Wubbel L, Muniz L, Ahmed A. , et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999; 18 (02) 98-104
  • 15 Chen CJ, Lin PY, Tsai MH. , et al. Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan. Pediatr Infect Dis J 2012; 31 (11) e196-e201
  • 16 Michelow IC, Olsen K, Lozano J. , et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004; 113 (04) 701-707
  • 17 Sun H, Chen Z, Yan Y, Huang L, Wang M, Ji W. Epidemiology and clinical profiles of Mycoplasma pneumoniae infection in hospitalized infants younger than one year. Respir Med 2015; 109 (06) 751-757
  • 18 Staugas R, Martin AJ. Secondary bacterial infections in children with proved Mycoplasma pneumoniae . Thorax 1985; 40 (07) 546-548
  • 19 Cimolai N, Wensley D, Seear M, Thomas ET. Mycoplasma pneumoniae as a cofactor in severe respiratory infections. Clin Infect Dis 1995; 21 (05) 1182-1185
  • 20 Franz A, Adams O, Willems R. , et al. Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol 2010; 48 (04) 239-245
  • 21 Honkinen M, Lahti E, Österback R, Ruuskanen O, Waris M. Viruses and bacteria in sputum samples of children with community-acquired pneumonia. Clin Microbiol Infect 2012; 18 (03) 300-307
  • 22 Shimizu T, Kida Y, Kuwano K. Mycoplasma pneumoniae-derived lipopeptides induce acute inflammatory responses in the lungs of mice. Infect Immun 2008; 76 (01) 270-277
  • 23 Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother 2010; 16 (03) 162-169
  • 24 Almasri M, Diza E, Papa A, Eboriadou M, Souliou E. Mycoplasma pneumoniae respiratory tract infections among Greek children. Hippokratia 2011; 15 (02) 147-152